Eh.. it might. Harvoni and its relatives are a cure for HepC. They charge about a lifetime's worth of liver treatment for a 3 month supply after which you're most likely cured. Over here one course of Harvoni is worth over 110 average monthly supplies of Humira (a rather expensive biological blockbuster RA/Crohn's drug). Insulin costs 5-10 times less depending on the user... I'm comparing apples to orange but you probably get the idea. Chronic illness is profitable but curing it yields a higher margin as your patient will likely survive the full course.
If/when it hits the market the pricetag would be about a lifetime's+ supply of insulin probably.
Great article to start the day. Thanks for sharing.